Add To Watchlist
Share URL
About The Company
CEO
Mr. Robert B. Ford
Market Cap
185.49 Billion USD
Sector
Healthcare
Website
https://www.abbott.comLast Update
2/22/2024, 12:00:00 PM
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Read More
Overview
Value
22
Growth
62
Health
60
Management
62
Analyst Opinion
91
Total
54
All Scores Out Of 100
Best Features
- Very strong cashflow and earnings growth
- Has a low level of debt
- Low risk of bankruptcy
- Has strong financial health
- Liked by analysts
- Has strong dividend growth
- Very safe dividend
Risk Factors
- Earnings have declined recently
- There is a history of diluting shareholders
- Disliked by Twitter users
- Price-to-earnings ratio of 35.2 is higher than the market average (19.6x)
- High preportion of income is paid as dividend
Market Peers
ABT
Key Figures
PE Ratio (TTM)
35.21
Margin Of Safety (DCF)
2.22%
Revenue Growth (5 Year Average)
10.06%
Ratings Consensus
Strong Buy
Share Buybacks
-0.31%
Dividend Yeild (TTM)
1.77%
Valuation
Value Score
22
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 104.4 USD ✘
Current Price: 115.5 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
35.21x
Free Cashflow Yeild
2.52%
PE/Earnings Growth
N/A
Price/Book
5.16x
Growth
Growth Score
62
- ✔ 5 Year Average Earnings growth of 23.23% is higher than the market average (14.48%)
- ✔ 5 Year Average Cashflow growth of 14.04% is higher than the market average (12.35%)
- ✘ 5 Year Average Revenue growth of 10.06% is lower than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ Earnings growth has slowed this year
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
10.06%
Earnings Growth
23.23%
Cashflow Growth
14.04%
Health
Health Score
60
Altman Z Score
5.22
Piostroski Score
7.00
Debt/Equity
0.66x
Current Assets/Liabilities
1.63x
Free Cashflow/Total Debt
0.32x
Debt/Capital
0.96x
Dividend
Secure Dividend Score
75
- ✔ Very safe
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of 1.77% is less than the market average (1.85%)
- ✘ Long term dividend payout ratio of 113.75% is high and may limit growth
- ✘ Payout ratio (TTM) of 62.14% is higher than the average (40%)
- ✘ Dividend growth has been slowing recently
Dividend Yeild
1.77%
Dividend Growth
3.34%
Payout Ratio (Earnings)
62.14%
Payout Ratio (Cashflow)
70.29%
Management
Management Score
62
- ✔ Has issued new shares to finance growth when share price is high
- ✔ Has returned higher dividends when earnings have risen
- ✔ Return-on-equity of 18.49% is higher than the market average (15%)
- ✔ Return-on-capital-employed of 14.13% is higher than the market average (10%)
- ✘ Has a history of diluting shareholders to finance activity
Average Buybacks/Dilution
-0.31%
Recent Buybacks/Dilution
-2.04%
5 Year Price Volitility
23.31%
Return On Assets
9.11%
Return On Capital Employed
14.13%
Return On Equity
18.49%
Return On Free Cashflow
N/A
Return On Investments
643.70%
Analysts
Analyst Opinion
91
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Abbott Laboratories
Currency
USD
Beta
0.662568
Vol Avg
4766529
Ceo
Mr. Robert B. Ford
Cik
0000001800
Cusip
002824100
Exchange
New York Stock Exchange
Full Time Employees
115000
Industry
Medical Devices
Sector
Healthcare
Ipo Date
1980-03-17
Address
100 Abbott Park Road
City
North Chicago
State
IL
Country
US
Zip
60064-6400
Phone
224 667 6100
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
28
Twitter Sentiment
0.00
Stocktwits Sentiment
56.00